Skip to content
10-Q

Quarterly Report

NEOPHOTONICS CORP

0001227025-22-000046

← back to feed
Filed
Apr 28, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 22, 2022 53.47M sh
Shares Diluted Q1 2022 · Mar 31, 2022 53.15M sh
Shares Diluted Q1 2022 · Mar 31, 2021 50.72M sh
Capex Q1 2022 · Mar 31, 2022 $2.04M
Capex Q1 2022 · Mar 31, 2021 $1.91M
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$11.44M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$8.94M
Short Term Debt Q1 2022 · Mar 31, 2022 $0
Short Term Debt Q1 2022 · Dec 31, 2021 $14.91M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $79.04M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $77.83M
Stockholders Equity Q1 2022 · Mar 31, 2022 $151.51M
Stockholders Equity Q1 2022 · Dec 31, 2021 $152.96M
Stockholders Equity Q1 2022 · Mar 31, 2021 $169.66M
Stockholders Equity Q1 2022 · Dec 31, 2020 $180.41M
Current Liabilities Q1 2022 · Mar 31, 2022 $97.57M
Current Liabilities Q1 2022 · Dec 31, 2021 $105.98M
Total Liabilities Q1 2022 · Mar 31, 2022 $172.72M
Total Liabilities Q1 2022 · Dec 31, 2021 $152.61M
Current Assets Q1 2022 · Mar 31, 2022 $250.41M
Current Assets Q1 2022 · Dec 31, 2021 $230.06M
Total Assets Q1 2022 · Mar 31, 2022 $324.23M
Total Assets Q1 2022 · Dec 31, 2021 $305.57M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.06
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.21
Eps Basic Q1 2022 · Mar 31, 2022 −$0.06
Eps Basic Q1 2022 · Mar 31, 2021 −$0.21
Sga Expense Q1 2022 · Mar 31, 2022 $9.79M
Sga Expense Q1 2022 · Mar 31, 2021 $7.29M
Rd Expense Q1 2022 · Mar 31, 2022 $15.1M
Rd Expense Q1 2022 · Mar 31, 2021 $13.1M
Net Income Q1 2022 · Mar 31, 2022 −$3.3M
Net Income Q1 2022 · Mar 31, 2021 −$10.69M
Operating Income Q1 2022 · Mar 31, 2022 −$2.84M
Operating Income Q1 2022 · Mar 31, 2021 −$11.08M
Gross Profit Q1 2022 · Mar 31, 2022 $27.29M
Gross Profit Q1 2022 · Mar 31, 2021 $13.34M
Cost Of Revenue Q1 2022 · Mar 31, 2022 $61.98M
Cost Of Revenue Q1 2022 · Mar 31, 2021 $47.59M
Revenue Q1 2022 · Mar 31, 2022 $89.27M
Revenue Q1 2022 · Mar 31, 2021 $60.93M